Morgan Stanley Maintains Overweight on P10, Lowers Price Target to $13
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Michael Cyprys has maintained an Overweight rating on P10 (NYSE:PX) but lowered the price target from $14 to $13.
October 18, 2023 | 3:17 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Morgan Stanley has maintained an Overweight rating on P10 but lowered the price target from $14 to $13.
The news is directly related to P10. While the Overweight rating indicates that Morgan Stanley expects the stock to outperform, the lowering of the price target could create some uncertainty among investors, potentially impacting the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100